Aquaretic and hormonal effects of a vasopressin V(2) receptor antagonist after acute and long-term treatment in rats (Q73689210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Aquaretic and hormonal effects of a vasopressin V(2) receptor antagonist after acute and long-term treatment in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Lacour C

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Galindo G

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Canals F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Segondy D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Cazaubon C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Serradeil-Le Gal C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Roccon A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Nisato D

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

131-138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Oxytocin and arginine vasopressin stimulate steroid secretion by the isolated perfused rat adrenal gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Chronic blockade of vasopressin receptors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Receptors to vasopressin and other hormones in the mammalian kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Effect of vasopressin V (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

The osmoregulation of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

Vasopressin and oxytocin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900088-1

10.1016/S0014-2999(00)00088-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771045%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference